B

Bexson Biomedical

14 employees

Bexson Biomedical is developing a unique formulation of ketamine for chronic and acute pain disorders.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Health Care
Pharmaceutical

Date founded

2017

Funding rounds raised

Total raised

$4.8M

from 2 investors over 2 rounds

B

Bexson Biomedical raised $4.8M on February 2, 2021

Investors: Noetic Fund and Lionheart Ventures

FAQ